Actor portrayal

Treatment for Parkinson's OFF Periods

Conduct a telemedicine visit with a board-certified neurologist. If you are taking carbidopa/levodopa and INBRIJA is determined to be appropriate for you, your prescription will be sent to a specialty pharmacy. The cost of your treatment for Parkinson’s OFF periods will be determined by the specialty pharmacy based on your insurance.

This telemedicine platform is available for patients with commercial insurance. Unfortunately, it is not available for federally insured patients.

$45.00 / Physician Visit

The physician visit fee may be eligible for reimbursement through your insurance. You can use your HSA, FSA, or a credit card for this payment.

request physician visit


Do not use INBRIJA if you take or have taken a nonselective monoamine
oxidase inhibitor such as phenelzine or tranylcypromine within the last 2 weeks.

Please see below for additional Important Safety Information.

  • Meet Your Telehealth Healthcare Providers

    Board-Certified, Licensed Neurologists
    UpScript is an independent provider of telehealth services. In UpScript’s 20 years in business, over a million patients have used the platform to meet with healthcare providers licensed in their state.

    Safe, Confidential, Appointments From Home
    You’ll have access to board-certified neurologists who can talk to you about treatment for Parkinson’s OFF periods and to make sure that INBRIJA is the right fit for you. You can speak to the provider over the phone or through video, and can do so safely and confidentially from the comfort of your own home.


    Actor portrayal

Additional Important Safety Information


Before using INBRIJA, tell your healthcare provider about your medical conditions, including:


  • asthma, chronic obstructive pulmonary disease (COPD), or any chronic lung disease

  • daytime sleepiness, sleep disorders, sleepiness/drowsiness without warning, or use of medicine that increases sleepiness,
    including antidepressants or antipsychotics

  • dizziness, nausea, sweating, or fainting when standing up

  • abnormal movement (dyskinesia)

  • mental health problems such as hallucinations or psychosis

  • uncontrollable urges like gambling, sexual urges, spending money, or binge eating

  • glaucoma

  • pregnancy or plans to become pregnant. It is unknown if INBRIJA will harm an unborn baby.

  • breastfeeding or plans to breastfeed. Levodopa can pass into breastmilk and it is unknown if it can harm the baby.

Tell your healthcare provider if you take:


  • MAO‐B inhibitors

  • dopamine (D2) antagonists (including phenothiazines, butyrophenones, risperidone, metoclopramide)

  • isoniazid

  • iron salts or multivitamins that contain iron salts

Do not drive, operate machinery, or do other activities until you know how INBRIJA affects you. Sleepiness and falling asleep suddenly can
happen as late as a year after treatment is started.


Tell your healthcare provider if you experience the following side effects:


  • falling asleep during normal daily activities with or without warning. If you become drowsy, do not drive or do activities where you
    need to be alert. Chances of falling asleep during normal activities increases if you take medicine that cause sleepiness.

  • withdrawal-emergent hyperpyrexia and confusion (fever, stiff muscles, or changes in breathing and heartbeat) if you suddenly stop
    using INBRIJA or carbidopa/levodopa, or suddenly lower your dose of carbidopa/levodopa.

  • low blood pressure when standing up (that may be with dizziness, fainting, nausea, and sweating). Get up slowly after sitting/lying

  • hallucinations and other psychosis – INBRIJA may cause or worsen seeing/hearing/believing things that are not real; confusion,
    disorientation, or disorganized thinking; trouble sleeping; dreaming a lot; being overly suspicious or feeling people want to harm you;
    acting aggressive; and feeling agitated/restless.

  • unusual uncontrollable urges such as gambling, binge eating, shopping, and sexual urges has occurred in some people using medicine
    like INBRIJA.

  • uncontrolled, sudden body movements (dyskinesia) may be caused or worsened by INBRIJA. INBRIJA may need to be stopped or other
    Parkinson’s medicines may need to be changed.

  • bronchospasm – people with asthma, COPD, or other lung diseases may wheeze or have difficulty breathing after inhaling INBRIJA. If
    this occurs, stop taking INBRIJA and seek immediate medical attention.

  • increased eye pressure in patients with glaucoma. Your healthcare provider should monitor this.

  • changes in certain lab values including liver tests

The most common side effects of INBRIJA are cough, upper respiratory tract infection, nausea, and change in the color of saliva or spit.


Do not orally inhale more than 1 dose (2 capsules) for any OFF period. Do not take more than 5 doses (10 capsules) in a day.



INBRIJA is a prescription medicine used when needed for OFF episodes in adults with Parkinson’s treated with regular
carbidopa/levodopa medicine. INBRIJA does not replace regular carbidopa/levodopa medicine.


Please see the Patient Information Leaflet.


INBRIJA and the INBRIJA logo are trademarks of Acorda Therapeutics, Inc.
© 2021 Acorda Therapeutics, Inc. All rights reserved.

07/21 INB10320


Customer Service Hours:
Monday - Thursday 6:00am to 7:00pm
Friday 6:00am to 6:00pm
Saturday 8:00am to 4:00pm
Sunday 8:00am to 4:00pm
(Times displayed in Pacific Standard Time)

Customer Support:

Complaint Dept:


Toll Free Customer Support:

(877) 353-0310


PO Box 6552
Scottsdale, AZ 85261

In case of medical emergency, please contact your local Physician or hospital for Immediate care.
Do not rely on your online Physician for emergency medical care.